{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:25:46Z","timestamp":1774416346938,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T00:00:00Z","timestamp":1502496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00417-017-3763-1","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T04:42:30Z","timestamp":1502512950000},"page":"2135-2140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion"],"prefix":"10.1007","volume":"255","author":[{"given":"Masaaki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,12]]},"reference":[{"issue":"6","key":"3763_CR1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","volume":"117","author":"DM Brown","year":"2010","unstructured":"Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S et al (2010) Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117(6):1124\u20131133.e1","journal-title":"Ophthalmology"},{"issue":"5","key":"3763_CR2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ophtha.2016.01.011","volume":"123","author":"M Larsen","year":"2016","unstructured":"Larsen M, Waldstein SM, Boscia F, Gerding H, Mon\u00e9s J et al (2016) Individualized Ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study. Ophthalmology 123(5):1101\u20131111","journal-title":"Ophthalmology"},{"issue":"3","key":"3763_CR3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bjophthalmol-2012-301504","volume":"97","author":"FG Holz","year":"2013","unstructured":"Holz FG, Roider J, Ogura Y, Korobelnik JF, Simader C et al (2013) VEGF trap-eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study. Br J Ophthalmol 97(3):278\u2013284","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3763_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, RETAIN Study Group et al (2014) Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121(1):209\u2013219","journal-title":"Ophthalmology"},{"issue":"7","key":"3763_CR5","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ophtha.2015.04.006","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA, Hafiz G, Mir TA et al (2015) Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial. Ophthalmology 122(7):1426\u20131437","journal-title":"Ophthalmology"},{"key":"3763_CR6","first-page":"371","volume":"79","author":"WR Green","year":"1981","unstructured":"Green WR, Chan CC, Hutchins GM et al (1981) Central retinal vein occlusion: a prospective histopathologic study of 20 eyes in 28 cases. Trans Am Ophthalmol Soc 79:371\u2013442","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3763_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02175453","volume":"225","author":"BE Allf","year":"1987","unstructured":"Allf BE, de Juan E Jr (1987) In vivo cannulation of retinal micropuncture of retinal vessels. Graefes Arch Clin Exp Ophthalmol 225:221\u2013225","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"3763_CR8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ajo.2004.06.083","volume":"138","author":"MK Tameesh","year":"2004","unstructured":"Tameesh MK, Lakhanpal RR, Fujii GY, Javaheri M, Shelley TH et al (2004) Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol 138(5):829\u2013839","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3763_CR9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/archopht.118.1.138","volume":"118","author":"WM Tang","year":"2000","unstructured":"Tang WM, Han DP (2000) A study of surgical approaches to retinal vascular occlusions. Arch Ophthalmol 118(1):138\u2013143","journal-title":"Arch Ophthalmol"},{"key":"3763_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1167\/iovs.11-8486","volume":"53","author":"LO Hattenbach","year":"2012","unstructured":"Hattenbach LO, Puchta J, Hilgenberg I (2012) Experimental endoscopic endovascular cannulation: a novel approach to thrombolysis in retinal vessel occlusion. Invest Ophthalmol Vis Sci 53:42\u201346","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3763_CR11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0002-9394(98)00086-5","volume":"126","author":"JN Weiss","year":"1998","unstructured":"Weiss JN (1998) Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 126:142\u2013144","journal-title":"Am J Ophthalmol"},{"key":"3763_CR12","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/S0161-6420(01)00875-2","volume":"108","author":"JN Weiss","year":"2001","unstructured":"Weiss JN, Bynoe LA (2001) Injection of tissue Plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 108:2249\u20132257","journal-title":"Ophthalmology"},{"key":"3763_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00006982-200507000-00014","volume":"25","author":"LA Bynoe","year":"2005","unstructured":"Bynoe LA, Hutchins RK, Lazarus HS et al (2005) Retinal endovascular surgery for central retinal vein occlusion. Retina 25:625\u2013632","journal-title":"Retina"},{"issue":"4","key":"3763_CR14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ophtha.2006.06.064","volume":"114","author":"N Feltgen","year":"2007","unstructured":"Feltgen N, Junker B, Agostini H, Hansen LL (2007) Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 114(4):716\u2013723","journal-title":"Ophthalmology"},{"key":"3763_CR15","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1167\/iovs.11-7327","volume":"52","author":"K Kadonosono","year":"2011","unstructured":"Kadonosono K, Yamane S, Arakawa A et al (2011) An experimental study of retinal endovascular surgery with a microfabricated needle. Invest Ophthalmol Vis Sci 52:5790\u20135793","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3763_CR16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamaophthalmol.2013.2585","volume":"131","author":"K Kadonosono","year":"2013","unstructured":"Kadonosono K, Yamane S, Arakawa A et al (2013) Endovascular cannulation with a microneedle for central retinal vein occlusion. JAMA Ophthalmol 131:783\u2013786","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"3763_CR17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2010.194464","volume":"95","author":"H Keino","year":"2011","unstructured":"Keino H, Okada AA, Watanabe T, Taki W (2011) Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet\u2019s disease on infliximab therapy. Br J Ophthalmol 95(9):1245\u20131250","journal-title":"Br J Ophthalmol"},{"key":"3763_CR18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000068980","volume":"217","author":"SS Hayreh","year":"2003","unstructured":"Hayreh SS (2003) Management of central retinal vein occlusion. Ophthalmologica 217:167\u2013188","journal-title":"Ophthalmologica"},{"key":"3763_CR19","first-page":"pp1039","volume-title":"Central retinal vein occlusion","author":"P Hahn","year":"2013","unstructured":"Hahn P, Mruthyunjaya P, Fekrat S (2013) Central retinal vein occlusion, 5th edn. Elsevier, London, pp pp1039\u2013pp1049","edition":"5"},{"issue":"7","key":"3763_CR20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/IAE.0b013e3181a3b870","volume":"29","author":"LO Hattenbach","year":"2009","unstructured":"Hattenbach LO, Friedrich Arndt C, Lerche R, Scharrer I, Baatz H, Margaron F, Richard G, Behrens-Baumann W, Ohrloff C (2009) Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Retina 29(7):932\u2013940","journal-title":"Retina"},{"issue":"8","key":"3763_CR21","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/IAE.0000000000000111","volume":"34","author":"T Brynskov","year":"2014","unstructured":"Brynskov T, Kemp H, S\u00f8rensen TL (2014) Intravitreal ranibizumab for retinal vein occlusion through 1 year in clinical practice. Retina 34(8):1637\u20131643","journal-title":"Retina"},{"key":"3763_CR22","doi-asserted-by":"publisher","first-page":"0","DOI":"10.5301\/ejo.5000943","volume":"28","author":"S Vaz-Pereira","year":"2017","unstructured":"Vaz-Pereira S, Marques IP, Matias J et al (2017) Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal. Eur J Ophthalmol 28:0. doi:\n10.5301\/ejo.5000943","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"3763_CR23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ophtha.2015.10.030","volume":"123","author":"TA Mir","year":"2016","unstructured":"Mir TA, Kherani S, Hafiz G et al (2016) Changes in retinal nonperfusion associated with suppression of vascular endothelial growth factor in retinal vein occlusion. Ophthalmology 123(3):625\u2013634","journal-title":"Ophthalmology"},{"issue":"4","key":"3763_CR24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/IAE.0b013e31826af52d","volume":"33","author":"LH Chuang","year":"2013","unstructured":"Chuang LH, Wang NK, Chen YP et al (2013) Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage. Retina 33(4):798\u2013802","journal-title":"Retina"},{"key":"3763_CR25","first-page":"219","volume":"99","author":"MJ Elman","year":"2001","unstructured":"Elman MJ, Raden RZ, Carrigan A (2001) Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 99:219\u2013221","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"3763_CR26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00006982-200312000-00006","volume":"23","author":"NG Ghazi","year":"2003","unstructured":"Ghazi NG, Noureddine B, Haddad RS, Jurdi FA, Bashshur ZF (2003) Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 23(6):780\u2013784","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3763-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T07:55:31Z","timestamp":1507881331000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3763-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,12]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3763"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3763-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,12]]}}}